03:31 PM EST - Medicago Inc. : and Cellectis plant sciences, a U.S.-based subsidiary of Cellectis Group, the specialist in genome engineering, today announced the successful completion of the first step in their research collaboration to improve therapeutic proteins produced in tobacco plants. Medicago Inc.
shares T.MDG are trading down $0.025 at $0.45.
